Eva E. Schaake
Papers
5
Total Citations
59
H-Index
4
About
Dr. Eva E. Schaake is a leading urologic oncologist whose research focuses on advancing precision imaging and treatment for prostate and urachal cancers. Her work centers on the clinical integration of prostate-specific membrane antigen (PSMA) PET/CT to improve oncological outcomes. In a landmark 2022 study (30 citations), she demonstrated that PSMA PET/CT-guided salvage radiation therapy significantly improves outcomes for men with biochemically recurrent prostate cancer, establishing a new standard for post-prostatectomy management. Dr. Schaake has also pioneered the use of sentinel node procedures to detect occult metastases in PSMA-negative patients, addressing a critical diagnostic gap. Beyond prostate cancer, she has evaluated the safety and efficacy of robot-assisted partial cystectomy for urachal cancer, advancing minimally invasive surgical options. Her recent development of a novel nomogram to predict salvage therapy outcomes (2024) further refines patient selection. With over 60 citations across her most impactful works, Dr. Schaake’s research is directly shaping clinical decision-making, reducing unnecessary treatments, and improving survival for patients with genitourinary malignancies.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5